07745 Jena, de
+49 (3641) 64-3949
Bessel Beam Plane Illumination Microscopy Enables Fast 3D Volume Imaging
ZEISS and the Janelia Research Campus Sign an Exclusive License Agreement for Commercialization / Patent Licensing(PresseBox) ( Jena / Maryland, USA, )
The technology uses special beam conditioning of the light sheet illumination. Enabling very thin illumination beams, it makes light sheet technology capable for applications in cell biology. Bessel beam plane illumination microscopy is extending non-invasive imaging which already is a common feature of the ZEISS light sheet microscope Lightsheet Z.1. The method offers a resolution better than existing technologies such as spinning disk. Users of the technology will be able to watch cellular and sub-cellular division processes in 4D - at ultra-high spatial and temporal resolution that was never achieved before with fluorescence imaging.
The Howard Hughes Medical Institute plays an influential role in advancing scientific research and education in the United States. Its scientists, located across the United States, have made important discoveries that advance our fundamental understanding of biology and its relation to human disease. In a complementary program at HHMI's Janelia Research Campus in Loudoun County, Virginia, leading scientists are pursuing long-term, high-risk, high-reward research in a campus designed to bring together researchers from disparate disciplines. The Institute also aims to transform science education into a creative, interdisciplinary endeavor that reflects the excitement of real research. For more information, visit www.hhmi.org.
ZEISS is an international leader in the fields of optics and optoelectronics. The more than 24,000 employees of ZEISS generated revenue of about 4.2 billion euros in fiscal year 2012/13. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. ZEISS has been contributing to technological progress for more than 160 years. ZEISS develops and produces solutions for the semiconductor, automotive and mechanical engineering industries, biomedical research and medical technology, as well as eyeglass lenses, camera and cine lenses, binoculars and planetariums. ZEISS is present in over 40 countries around the globe with more than 40 production facilities, around 50 sales and service locations and over 20 research and development sites. Carl Zeiss AG is fully owned by the Carl-Zeiss-Stiftung (Carl Zeiss Foundation).
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an firstname.lastname@example.org.